Evaluation of disk diffusion methods to detect low-level β-lactamase-negative ampicillin-resistant Haemophilus influenzae

APMIS

Volumn 119, Issue 6, 2011, Pages 385-392

  Nørskov Lauritsen, Niels ^a   Ridderberg, Winnie ^a   Erikstrup, Lise T ^a   Fuursted, Kurt ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

BLNAR; Cephalosporin resistance; ftsI; Susceptibility testing

Indexed keywords

AMPICILLIN; CEFACLOR; CEFUROXIME; NICOTINAMIDE ADENINE DINUCLEOTIDE;

AGAR DIFFUSION; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; DISK DIFFUSION; GENE SEQUENCE; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPICILLIN; AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFACLOR; CEFUROXIME; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS; REGRESSION ANALYSIS;

EID: 79955968264     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02745.x     Document Type: Article

References (33)

1. Turk DC, May JR. Haemophilus influenzae: Its Clinical Importance. London: The English Universities Press, 1967.
2. Vega R, Sadoff HL, Patterson MJ. Mechanisms of ampicillin resistance in Haemophilus influenzae type B. Antimicrob Agents Chemother 1976;9:164-8.
3. Medeiros AA, Levesque R, Jacoby GA. An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b. Antimicrob Agents Chemother 1986;29:212-5.
4. Markowitz SM. Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae. Antimicrob Agents Chemother 1980;17:80-3.
5. Mendelman PM, Chaffin DO, Stull TL, Rubens CE, Mack KD, Smith AL. Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother 1984;26:235-44.
6. Parr TR, Bryan LE. Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics. Antimicrob Agents Chemother 1984;25:747-53.
7. Kaczmarek FS, Gootz TD, Dib-Hajj F, Shang W, Hallowell S, Cronan M. Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob Agents Chemother 2004;48:1630-9.
8. García-Cobos S, Campos J, Román F, Carrera C, Pérez-Vázquez M, Aracil B, et al. Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method. Antimicrob Agents Chemother 2008;52:2407-14.
9. Trepod CM, Mott JE. Elucidation of essential and nonessential genes in the Haemophilus influenzae Rd cell wall biosynthetic pathway by targeted gene disruption. Antimicrob Agents Chemother 2005;49:824-6.
10. Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, et al. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001;45:1693-9.
11. Osaki Y, Sanbongi Y, Ishikawa M, Kataoka H, Suzuki T, Maeda K, et al. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae beta-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob Agents Chemother 2005;49:2834-9.
12. Hasegawa K, Kobayashi R, Takada E, Ono A, Chiba N, Morozumi M, et al. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J Antimicrob Chemother 2006;57:1077-82.
13. Skaare D, Allum AG, Anthonisen IL, Jenkins A, Lia A, Strand L, et al. Mutant ftsI genes in the emergence of penicillin-binding protein-mediated beta-lactam resistance in Haemophilus influenzae in Norway. Clin Microbiol Infect 2010;16:1117-24.
14. Blackall P, Nørskov-Lauritsen N. Pasteurellaceae- the view from the diagnostic laboratory. In: Kuhnert P, Christensen H editors. Pasteurellaceae: Biology, Genomics and Molecular Aspects. Norfolk: Caister Academic Press, 2008: 229-261.
15. Jorgensen JH, Redding JS, Maher LA, Howell AW. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J Clin Microbiol 1987;25:2105-13.
16. Doern GV. In vitro susceptibility testing of Haemophilus influenzae: review of new National Committee for Clinical Laboratory Standards recommendations. J Clin Microbiol 1992;30:3035-8.
17. British Society for Antimicrobial Chemotherapy. BSAC Methods for Antimicrobial Susceptibility Testing. Accessed on November 22nd, 2009.
18. The Swedish Reference Group for Antibiotics (SRGA) and its subcommittee on methodology (SRGA-M). Disk diffusion (SRGA). 2. Medium with defibrinated horse blood and NAD - medium B in tables. Accessed on November 22nd, 2009.
19. Mendelman PM, Wiley EA, Stull TL, Clausen C, Chaffin DO, Onay O. Problems with current recommendations for susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother 1990;34:1480-4.
20. Heelan JS, Chesney D, Guadagno G. Investigation of ampicillin-intermediate strains of Haemophilus influenzae by using the disk diffusion procedure and current National Committee for Clinical Laboratory Standards guidelines. J Clin Microbiol 1992;30:1674-7.
21. Norskov-Lauritsen N. Detection of cryptic genospecies misidentified as Haemophilus influenzae in routine clinical samples by assessment of marker genes fucK, hap, and sodC. J Clin Microbiol 2009;47:2590-2.
22. Frimodt-Møller N, Højbjerg T, Hvass E, Møller S, Mortensen I, Thomsen VF. Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone. APMIS [B] 1985;93:181-8.
23. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement (M100-S19). Wayne, PA, USA: CLSI, 2009.
24. Tristram SG, Nichols S. A multiplex PCR for beta-lactamase genes of Haemophilus influenzae and description of a new blaTEM promoter variant. J Antimicrob Chemother 2006;58:183-5.
25. Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, et al. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 2002;46:2208-18.
26. Schumacher H, Hoffmann S, Holmboe C, Møller JK. A procedure for evaluation and documentation of susceptibility test methods using the susceptibility of Klebsiella pneumoniae to ciprofloxacin as a model. J Antimicrob Chemother 2001;48:493-500.
27. Nettleman MD. Receiver operator characteristic (ROC) curves. Infect Control Hosp Epidemiol 1988;9:374-7.
28. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - Tenth Edition (M02-A10). Wayne, PA, USA: CLSI, 2009.
29. European Committee on Antibiotic Susceptibility Testing. EUCAST Clinical Breakpoint Table v. 1.0. Accessed on December 28th, 2009.
30. Barry AL, Fuchs PC, Brown SD. Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media. Antimicrob Agents Chemother 2001;45:1585-8.
31. Hotomi M, Fujihara K, Billal DS, Suzuki K, Nishimura T, Baba S, et al. Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan. Antimicrob Agents Chemother 2007;51:3969-76.
32. Clinical and Laboratory Standards Institute. Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters; Approved Guideline-Third Edition (M23-A3). Wayne, PA, USA: CLSI, 2008.
33. Jones RN, Hindler J, Doern GV, Thornsberry C, Gerlach EH. The re-evaluation of the NCCLS ampicillin susceptibility tests with Haemophilus Test Medium: new interpretive criteria for the disk diffusion method. Antimicrob Newsl 1992;8:31-5.